We found 11 online brokers that are appropriate for Trading Genetic Engineering Stocks And Shares Investment Platforms.
The field of genetic engineering is a very complex one. It is the process of inserting specific DNA into the target genome through artificial methods. It is done to help treat genetic diseases like diabetes and hereditary muscular and neurological disorders. However, in the last few years, the public has shown a lot of interest in this technology, and many companies are engaged in it.
Research and development activities have been going on for quite a few years now, and most companies are involved in the process of finding solutions for various genetic problems. These companies conduct research and develop tools that help in treating genetic diseases. They also use the resources designed in the study to ensure that the research findings are well utilised and help find the best solutions. Apart from this, they provide solutions to other problems in the medical world. In this regard, they also make sure that products they manufacture are made using the best technology and are tested rigorously for their efficiency and safety.
The field of genetic technology has grown phenomenally within the past decade. There have been several successful ventures in this field. These companies dealing with genetic diseases have seen a tremendous increase in their revenues during the last few years. The revenues and profits of these companies have quadrupled in the last few years.
As of today, gene therapy has helped many people afflicted with genetic disorders like sickle cell anaemia and diabetes to lead normal and healthy lives. Several companies are engaged in providing gene therapy services, and they make huge profits every year. Here are some of the best Genetic Engineering stocks.
The company Cellectis is working on a new product called Gene drives. It will enable the company to deliver a genetically engineered animal to every home in the USA in a few years. This technology will enable the company to cure diseases through genetics and create super-animals that are better than their counterparts by changing genetic makeup. If this technology is successful, Cellectis stock could go up significantly.
Once inserted, the Cellectis scientists successfully used genetic engineering to insert the missing piece. They bred the newly created animals to improve and enhance their strength and agility. They tried to transfer those improvements back into the wild and back to the Cellectis genetically engineered animal and found they had an excellent result. The Cellectis scientists then showed the results to the FDA and were approved to produce the first genetically engineered animal.
CRISPR Therapeutics corporation is a Swiss, American biotechnology company based in Zug. As an innovative medical device, CRISPR Therapeutics is an acronym for 'Covid-19 Therapeutic Response Modifiers'. Scientists in Massachusetts discovered it. This technology has been licensed to various pharmaceutical companies. One of them, Merck KGAa, is currently investing 60 million in the business. Other major firms working with the company are Genexigma, Novartis and Ciba foundation.
The CRISPR Therapeutics company has three main research facilities. The first is a located enzyme laboratory of the University of Tubingen. It is researching gen script biotech, which integrates genetic engineering with exogenous DNA technologies to generate diverse forms of proteins. In other words, this company is involved in developing CRISPR Therapeutics products with applications in nutrition and agriculture.
Editas Medicine is a biotech company focused on finding medical solutions for genetic diseases and conditions. The company's core products are GenFX and Gene Tuner, both of which are gene therapies designed to treat genetic disorders and improve the health of humans and animals.
Editas Medicine's primary product is a form of genetic engineering used to treat genetic disorders like cystic fibrosis and sickle cell anaemia. Editas Medicine stock is also working on effective treatment for muscular dystrophy. Other diseases that can benefit from Editas' products include multiple sclerosis, Alzheimer's, Parkinson's and Huntington's disease, and many others. The company holds majority stakes in these projects and is looking forward to large profits from each one of them.
The Intellia Therapeutics Genetic Engineering company has generated a lot of controversies. Intellia, however, has presented itself as an entity that is entirely different from conventional pharmaceuticals. They claim that genetic therapies they carry are completely safe and do not pose any immediate threats to any patient. The company itself also points out that it does not treat any disease.
However, critics argue that this company is taking an additional step into the realm of genetic engineering. Because the company develops its own products, it can possibly patent the therapy it creates and therefore have sole rights to that therapy rather than negotiate licensing agreements with other companies. Additionally, the company is in negotiations with the Food and Drug Administration for the rights to another therapy called Enbrel. While the FDA is examining Enbrel, the company is also engaged in efforts to file a lawsuit against GlaxoSmithKline, the major manufacturer of the chemotherapy drug Doxorubicin, which it claims is defective.
Intellia Therapeutics has invested heavily in its own intellectual property, and it is now trying to apply that knowledge to other areas. In addition, the company has developed its own genetically engineered cholesterol-reducing drugs. Those drugs are not expected to come to market anytime soon. The drug is the focus of several lawsuits, and Intellia is looking to ride the wave of controversy to make its mark in the pharmaceutical world.
We have conducted extensive research and analysis on over multiple data points on Genetic Engineering Investing to present you with a comprehensive guide that can help you find the most suitable Genetic Engineering Investing. Below we shortlist what we think are the best Genetic Engineering Stocks And Shares Investment Platforms after careful consideration and evaluation. We hope this list will assist you in making an informed decision when researching Genetic Engineering Investing.
Selecting a reliable and reputable online Genetic Engineering Stocks And Shares Investment Platforms trading brokerage involves assessing their track record, regulatory status, customer support, processing times, international presence, and language capabilities. Considering these factors, you can make an informed decision and trade Genetic Engineering Stocks And Shares Investment Platforms more confidently.
Selecting the right online Genetic Engineering Stocks And Shares Investment Platforms trading brokerage requires careful consideration of several critical factors. Here are some essential points to keep in mind:
Our team have listed brokers that match your criteria for you below. All brokerage data has been summarised into a comparison table. Scroll down.
When choosing a broker for Genetic Engineering Stocks And Shares Investment Platforms trading, it's essential to compare the different options available to you. Our Genetic Engineering Stocks And Shares Investment Platforms brokerage comparison table below allows you to compare several important features side by side, making it easier to make an informed choice.
By comparing these essential features, you can choose a Genetic Engineering Stocks And Shares Investment Platforms broker that best suits your needs and preferences for Genetic Engineering Stocks And Shares Investment Platforms. Our Genetic Engineering Stocks And Shares Investment Platforms broker comparison table simplifies the process, allowing you to make a more informed decision.
Here are the top Genetic Engineering Stocks And Shares Investment Platforms.
Compare Genetic Engineering Stocks And Shares Investment Platforms brokers for min deposits, funding, used by, benefits, account types, platforms, and support levels. When searching for a Genetic Engineering Stocks And Shares Investment Platforms broker, it's crucial to compare several factors to choose the right one for your Genetic Engineering Stocks And Shares Investment Platforms needs. Our comparison tool allows you to compare the essential features side by side.
All brokers below are Genetic Engineering Stocks And Shares Investment Platforms. Learn more about what they offer below.
You can scroll left and right on the comparison table below to see more Genetic Engineering Stocks And Shares Investment Platforms that accept Genetic Engineering Stocks And Shares Investment Platforms clients.
Broker |
IC Markets
![]() |
Roboforex
![]() |
eToro
![]() |
XTB
![]() |
XM
![]() |
Pepperstone
![]() |
AvaTrade
![]() |
FP Markets
![]() |
EasyMarkets
![]() |
SpreadEx
![]() |
FXPro
![]() |
---|---|---|---|---|---|---|---|---|---|---|---|
Rating | |||||||||||
Regulation | Seychelles Financial Services Authority (FSA) (SD018) | RoboForex Lid is regulated by Belize FSC, License No. 000138/7, reg. number 000001272. RoboForex Ltd, which is an (A category) member of The Financial Commission, also is a participant of its Compensation Fund | FCA (Financial Conduct Authority) eToro (UK) Ltd (FCA reference 583263), eToro (Europe) Ltd CySEC (Cyprus Securities Exchange Commission), ASIC (Australian Securities and Investments Commission) eToro AUS Capital Limited ASIC license 491139, CySec (Cyprus Securities and Exchange Commission under the license 109/10), FSAS (Financial Services Authority Seychelles) eToro (Seychelles) Ltd license SD076 | FCA (Financial Conduct Authority reference 522157), CySEC (Cyprus Securities and Exchange Commission reference 169/12), FSCA (Financial Sector Conduct Authority), XTB AFRICA (PTY) LTD licensed to operate in South Africa, KPWiG (Polish Securities and Exchange Commission), DFSA (Dubai Financial Services Authority), DIFC (Dubai International Financial Center), CNMV (Comisión Nacional del Mercado de Valores), KNF (Komisja Nadzoru Finansowego), IFSC (Belize International Financial Services Commission license number IFSC/60/413/TS/19) | Financial Services Commission (FSC) (000261/4) XM ZA (Pty) Ltd, Cyprus Securities and Exchange Commission (CySEC) (license 120/10) Trading Point of Financial Instruments Ltd, Australian Securities and Investments Commission (ASIC) (number 443670) Trading Point of Financial Instruments Pty Ltd | Financial Conduct Authority (FCA), Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), Federal Financial Supervisory Authority (BaFin), Dubai Financial Services Authority (DFSA), Capital Markets Authority of Kenya (CMA), Pepperstone Markets Limited is incorporated in The Bahamas (number 177174 B), Licensed by the Securities Commission of the Bahamas (SCB) number SIA-F217 | Australian Securities and Investments Commission (ASIC) Ava Capital Markets Australia Pty Ltd (406684), South African Financial Sector Conduct Authority (FSCA) Ava Capital Markets Pty Ltd (45984), Financial Services Agency (Japan FSA) Ava Trade Japan K.K. (1662), Financial Futures Association of Japan (FFAJ),, FFAJ, Abu Dhabi Global Markets (ADGM)(190018) Ava Trade Middle East Ltd (190018), Polish Financial Supervision Authority (KNF) AVA Trade EU Ltd, Central Bank of Ireland (C53877) AVA Trade EU Ltd, British Virgin Islands Financial Services Commission (BVI) BVI (SIBA/L/13/1049), Israel Securities Association (ISA) (514666577) ATrade Ltd, Financial Regulatory Services Authority (FRSA) | CySEC (Cyprus Securities and Exchange Commission) (371/18), ASIC AFS (Australian Securities and Investments Commission) (286354), FSP (Financial Sector Conduct Authority in South Africa) (50926), Financial Services Authority Seychelles (FSA) (130) | Cyprus Securities and Exchange Commission (CySEC) (079/07) Easy Forex Trading Ltd, Australian Securities and Investments Commission (ASIC) (Easy Markets Pty Ltd 246566), British Virgin Islands Financial Services Commission (BVI) EF Worldwide Ltd (SIBA/L/20/1135), Financial Sector Conduct Authority South Africa (FSA) EF Worldwide (PTY) Ltd (54018), FSC (Financial Services Commission) (SIBA/L/20/1135), FSCA (Financial Sector Conduct Authority) (54018) | FCA (Financial Conduct Authority) (190941), Gambling Commission (Great Britain) (8835) | FCA (Financial Conduct Authority) (509956), CySEC (Cyprus Securities and Exchange Commission) (078/07), FSCA (Financial Sector Conduct Authority) (45052), SCB (Securities Commission of The Bahamas) (SIA-F184), FSA (Financial Services Authority of Seychelles) (SD120) |
Min Deposit | 200 | 10 | 50 | No minimum deposit | 5 | No minimum deposit | 100 | 100 | 25 | No minimum deposit | 100 |
Funding |
|
|
|
|
|
|
|
|
|
|
|
Used By | 200,000+ | 730,000+ | 35,000,000+ | 1,000,000+ | 10,000,000+ | 400,000+ | 400,000+ | 200,000+ | 250,000+ | 60,000+ | 7,800,000+ |
Benefits |
|
|
|
|
|
|
|
|
|
|
|
Accounts |
|
|
|
|
|
|
|
|
|
|
|
Platforms | MT5, MT4, MetaTrader WebTrader, Mobile Apps, iOS (App Store), Android (Google Play), MetaTrader iPhone/iPad, MetaTrader Android Google Play, MetaTrader Mac, cTrader, cTrader Web, cTrader iPhone/iPad, cTrader iMac, cTrader Android Google Play, cTrader Automate, cTrader Copy Trading, TradingView, Virtual Private Server, Trading Servers, MT4 Advanced Trading Tools, IC Insights, Trading Central | MT4, MT5, R Mobile Trader, R StocksTrader, WebTrader, Mobile Apps, iOS (App Store), Android (Google Play), Windows | eToro Trading App, Mobile Apps, iOS (App Store), Android (Google Play), CopyTrading, Web | MT4, Mirror Trader, Web Trader, Tablet, Mobile Apps, iOS (App Store), Android (Google Play) | MT5, MT5 WebTrader, XM Apple App for iPhone, XM App for Android Google Play, Tablet: MT5 for iPad, MT5 for Android Google Play, XM App for iPad, XM App for iOS (App Store), Android (Google Play), Mobile Apps | MT4, MT5, cTrader,WebTrader, TradingView, Windows, Mobile Apps, iOS (App Store), Android (Google Play) | MT4, MT5, Web Trading, AvaTrade App, AvaOptions, Mac Trading, AvaSocial, Mobile Apps, iOS (App Store), Android (Google Play) | MT4, MT5, TradingView, cTrader, WebTrader, Mobile Trader, Mobile Apps, iOS (App Store), Android (Google Play) | easyMarkets App, Mobile Apps, iOS (App Store), Android (Google Play), Web Platform, TradingView, MT4, MT5 | Web, Mobile Apps, iOS (App Store), Android (Google Play), iPad App, iPhone App, TradingView | MT4, MT5, cTrader, FxPro WebTrader, FxPro Mobile Apps, iOS (App Store), Android (Google Play) |
Support |
|
|
|
|
|
|
|
|
|
|
|
Learn More |
Sign
Up with icmarkets |
Sign
Up with roboforex |
Sign
Up with etoro |
Sign
Up with xtb |
Sign
Up with xm |
Sign
Up with pepperstone |
Sign
Up with avatrade |
Sign
Up with fpmarkets |
Sign
Up with easymarkets |
Sign
Up with spreadex |
Sign
Up with fxpro |
Risk Warning | Losses can exceed deposits | Losses can exceed deposits | 51% of retail investor accounts lose money when trading CFDs with this provider. | 69% - 83% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74.12% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | 75-95 % of retail investor accounts lose money when trading CFDs | 71% of retail investor accounts lose money when trading CFDs with this provider | Losses can exceed deposits | Your capital is at risk | Losses can exceed deposits | 75.78% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider |
Demo |
IC Markets Demo |
Roboforex Demo |
eToro Demo |
XTB Demo |
XM Demo |
Pepperstone Demo |
AvaTrade Demo |
FP Markets Demo |
easyMarkets Demo |
SpreadEx Demo |
FxPro Demo |
Excluded Countries | US, IR, CA, NZ, JP | AU, BE, BQ, BR, CA, CW, CZ, DE, ES, EE, EU, FM, FR, FI, GW, ID, IR, JP, LR, MP, NL, PF, PL, RU, SE, SJ, SS, SL, SI, TL, TR, DO, US, IT, AT, PT, BG, HR, CY, DK, FL, GR, IE, LV, LT, MT, RO, SK, CH | ZA, ID, IR, KP, BE, CA, JP, SY, TR, IL, BY, AL, MD, MK, RS, GN, CD, SD, SA, ZW, ET, GH, TZ, LY, UG, ZM, BW, RW, TN, SO, NA, TG, SL, LR, GM, DJ, CI, PK, BN, TW, WS, NP, SG, VI, TM, TJ, UZ, LK, TT, HT, MM, BT, MH, MV, MG, MK, KZ, GD, FJ, PT, BB, BM, BS, AG, AI, AW, AX, LB, SV, PY, HN, GT, PR, NI, VG, AN, CN, BZ, DZ, MY, KH, PH, VN, EG, MN, MO, UA, JO, KR, AO, BR, HR, GL, IS, IM, JM, FM, MC, NG, SI, | US, IN, PK, BD, NG , ID, BE, AU | US, CA, IL, IR | AF, AS, AQ, AM, AZ, BY, BE, BZ, BT, BA, BI, CM, CA, CF, TD, CG, CI, ER, GF, PF, GP, GU, GN, GW, GY, HT, VA, IR, IQ, JP, KZ, LB, LR, LY, ML, MQ, YT, MZ, MM, NZ, NI, KP, PS, PR, RE, KN, LC, VC, WS, SO, GS, KR, SS, SD, SR, SY, TJ, TN, TM, TC, US, VU, VG, EH, ES, YE, ZW, ET | BE, BR, KP, NZ, TR, US, CA, SG | US, JP, NZ | US, IL, BC, MB, QC, ON, AF, BY, BI, KH, KY, TD, KM, CG, CU, CD, GQ, ER, FJ, GN, GW, HT, IR, IQ, LA, LY, MZ, MM, NI, KP, PW, PA, RU, SO, SS, SD, SY, TT, TM, VU, VE, YE | US, TR | US, CA, IR |
You can compare Genetic Engineering Stocks And Shares Investment Platforms ratings, min deposits what the the broker offers, funding methods, platforms, spread types, customer support options, regulation and account types side by side.
We also have an indepth Top Genetic Engineering Stocks And Shares Investment Platforms for 2025 article further below. You can see it now by clicking here
We have listed top Genetic Engineering Stocks And Shares Investment Platforms below.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 51% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
This communication is intended for information and educational purposes only and should not be considered investment advice or investment recommendation. Past performance is not an indication of future results.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Cryptoasset investing is highly volatile and unregulated in some EU countries. No consumer protection. Tax on profits may apply.
Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.